 Home > Chemicals Industry > China Chemical > The internationalization strategy of domestic pharmaceutical machine enterprises has taken new steps to drive performance growth

The internationalization strategy of domestic pharmaceutical machine enterprises has taken new steps to drive performance growth

 Last Update: 2022-02-23
 Source: Internet
 Author: User

Tags

factor 4

key technology

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market Analysis of Chemical Machinery Equipment Network ] After decades of precipitation, China's pharmaceutical equipment industry has changed the extensive production mode of the past, and gradually moved towards a stage of stable development with high precision and high quality, and the industry has been continuously transformed and upgraded.
More and more domestic pharmaceutical equipment companies have begun to deploy overseas markets and go international
.

Chemical Machinery Equipment Network Market Analysis Chemical Machinery Equipment

Judging from the 2020 annual report data disclosed by major pharmaceutical machine companies, some domestic pharmaceutical machine companies have continued to increase their overseas layout in recent years, and related businesses have grown significantly, and international layout has become an important factor for the future performance growth of these companies.
one of the strategies
.

For example, through relying on its own research and development and extensional mergers and acquisitions in recent years, Chutian Technology has begun to take shape in its strategic layout, and its strategic effect has also initially appeared.
In 2016, overseas sales accounted for 18.
89% of its total revenue
.
In 2017, the company increased its overseas layout by acquiring 75.
1% equity of Romaco, and successfully completed the follow-up acquisition of German Romaco company in 2020.
The global strategic layout is steadily advancing
.
The annual report shows that in 2020, the company's overseas performance will achieve steady growth, and foreign revenue will increase by 6.
63% year-on-year
.
Among them, ROMACO company achieved a net profit of 73.
7226 million yuan for the year, exceeding the performance target with a completion rate of 133.
73%
.

　　In terms of internationalization, Chutian Technology stated that in the future, it will accelerate the pace of international business expansion, establish a sales service center in key markets, and further build a global customer model point system
.
According to the company's plan, by 2025, the global annual sales of Chutian Technology will not be less than 20 billion, the annual net profit will not be less than 3 billion, the annual tax will not be less than 3 billion, and the total market value will reach 100 billion
.

　　Towards internationalization is also the original intention of domestic freeze dryer manufacturing giant Tofflon.
Tofflon started its internationalization strategy in 2004.
The company established joint ventures with foreign companies to improve the company's industrial chain.
Established subsidiaries in the United States and offices in Italy, Spain and many other countries to improve the company's overseas sales capabilities
.

　　According to the "2019 Annual Report" disclosed by the company, the company's overseas export revenue accounted for 25% of the company's total revenue
.
New financial data shows that in 2020, Tofflon's overseas revenue will still account for about 20%
.
The company has more than 10,000 sets of pharmaceutical equipment and pharmaceutical manufacturing systems serving more than 1,000 global pharmaceutical companies in more than 40 countries and regions around the world
.

Pharmaceutical equipment

　　Tofflon said that in 2021, the company will firmly focus on the development strategy of "systematization, internationalization, and digitalization", and in the fields of pharmaceutical equipment such as sterile injections, bioengineering, APIs, and oral solids, it will closely focus on the production process and Development direction, research and develop innovative products with forward-looking and independent intellectual property rights
.
At the same time, in the fields of cell preparation and food equipment, we continue to invest in research and development and technical cooperation, improve the industrial layout, enrich the variety of products, stabilize and expand the market share
.
In 2021, the company's operating income target is to strive for 3.
5 billion yuan
.

　　From the perspective of the industry, with the continuous advancement of national medical insurance cost control, volume-based procurement, consistency evaluation and other policies, the downward pressure on the domestic pharmaceutical industry is still great, but the pace of innovation by pharmaceutical companies has not stopped
.
According to data from the National Bureau of Statistics, from January to December 2020, the added value of industries above designated size in China's pharmaceutical manufacturing industry increased by 5.
9% year-on-year, and the investment in the pharmaceutical manufacturing industry increased by 28.
4% year-on-year, which shows the high market enthusiasm
.
With the new round of growth of investment in the pharmaceutical manufacturing industry, it will bring development opportunities to the pharmaceutical equipment industry
.

　　For pharmaceutical machine companies, under the new situation, while seizing the opportunities in the domestic market, by vigorously implementing the internationalization strategy and speeding up the process of internationalization, it is beneficial for the company to expand the right to speak in the international market, seize the commanding heights in the international competition, and improve the The competitiveness of domestic medicine machines is also conducive to improving the quality of domestic medicine machines, the quality of employees, and obtaining more new opportunities and advantages for overseas development
.

　　Original title: The internationalization strategy of domestic pharmaceutical machine enterprises has taken new steps to drive performance growth

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.